Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib

pharmaceutical-business-reviewSeptember 27, 2020

Tag: OnKure , Pfizer , OKI-179 , binimetinib , HDAC inhibitor

PharmaSources Customer Service